BRSR for FY 2025-26

Date: September 01, 2026 BSE Limited National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra – Kurla Complex, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip code-531599 Symbol: FDC Sub: Submission of Business Responsibility and Sustainability Report for Financial Year 2025-26. Ref: Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Dear Sir/Madam, Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Business Responsibility and Sustainability Report of the Company for the financial year 2025-26. You are requested to take the same on record. Thank you. Yours Sincerely, For FDC Limited Varsharani Katre Company Secretary & Legal Head M. No.: FCS-8948 Corporate Overview Statutory Reports Financial Statements FDC Limited 41. Environment, Health and Safety 43. Acknowledgements ‘Annexure-A’ The Environment, Health and Safety are a part of the The directors of your Company would like to record by BUSINESS RESPONSIBILITY & Management responsibilities and concerns. The Company gratitude and appreciation for the continued co-operation has been providing various kinds of medical assistance to and support received from the Medical fraternity, our the employees and their families. Periodic health checkups stakeholders, including the Central and State Government SUSTAINABILITY REPORT are carried out for all the employees. Employees are also Authorities, Stock Exchanges, Financial Institutions, educated on safety and precautionary measures to be Bankers, Analysts, Advisors, Local Communities, SECTION A: GENERAL DISCLOSURES undertaken on their job. Customers, Vendors, Business Partners, Shareholders, and Investors forming part of the Company. Let us also I. Details of the Listed Entity take this opportunity to thank our employees, whose 42. Significant and Material Orders Passed by the Regulators or Courts enthusiasm, energy, and passion, help us progress along Sr. Particulars Details our vision. Your faith and vote of confidence motivate us No There are no significant or material orders passed by any in pursuing greater opportunities, responsible growth and 1. Corporate Identity Number (CIN) of the Listed Entity L24239MH1940PLC003176 regulatory, tribunal or court that would impact the going enhanced delivery on our strategy. 2. Name of the Listed Entity FDC Limited concern status of the Company and its future operations. 3. Year of incorporation 1940 4. Registered office address FDC House, C-11 & 12, Dalia Industrial Estate, Oshiwara Village,Off New Link Road, Andheri - West, Mumbai - 400 053, Maharashtra, INDIA 5. Corporate address FDC House, C-11 & 12, Dalia Industrial Estate, Oshiwara Village,Off New Link Road, Andheri - West, Mumbai - 400 053, On behalf of the Board of Directors Maharashtra, INDIA For FDC Limited 6. E-mail investors@fdcindia.com 7. Telephone 91-(22)-69107100 SD/- SD/- 8. Website https://www.fdcindia.com/ 9. Financial year for which reporting is being done FY 2025-26 Mohan A. Chandavarkar Ashok A. Chandavarkar 10. Name of the Stock Exchange(s) where shares are listed National Stock Exchange of India Limited, BSE Ltd. Place: Mumbai Chairman & Managing Director Executive Director 11. Paid-up Capital Rs. 16,28,10,084 /- Date: May 27, 2026 DIN: 00043344 DIN: 00042719 12. Name and contact details (telephone, email address) Name : Ms. Varsharani Katre of the person who may be contacted in case of any Designation : Company Secretary & Legal Head queries on the BRSR report Telephone : 91-(22)-69107100 Email Id : varsharani.katre@fdcindia.com 13. Reporting boundary - Are the disclosures under this Standalone Basis report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). 14. Name of Assurance provider Not Applicable 15. Type of Assurance obtained Not Applicable II. Product / Services 16. Details of business activities (accounting for 90% of the turnover) Sr. Description of Main Description of Business Activity Percentage Turnover of the Entity No Activity 1 Pharmaceutical Manufacturing and marketing of pharmaceutical products 100% 17. Products/Services sold by the entity (accounting for 90% of turnover) Sr. Percentage of Total Product/Service NIC Code No Turnover contributed 1. Manufacture of pharmaceuticals, medicinal and chemical products 210 100% III. Operations 18. Number of locations where plants and/or operations/offices are situated: Location Number of plants No. of Offices Total National 9 22 31 International 0 2 2 62 Annual Report 2025-26 63 Corporate Overview Statutory Reports Financial Statements FDC Limited 19. Markets served by the entity 21. Participation/Inclusion/Representation of women a. Number of locations Sr. No. and Percentage of Females Category Total (A) No. No. (B) Percentage (B/A) Locations Number 1 Board of Directors 10 2 20% National (No. of States) 28 States and 7 Union 2 Key Management Personnel 2 1 50% Territories International (No. of Countries) 50+ countries 22. Turnover rate for permanent employees and workers (past 3 years) b. What is the contribution of exports as a percentage of the total turnover of the entity? FY 2025-26 FY 2024-25 FY 2023-24 Contribution of exports comprises of 17 percent of total turnover of the entity. FDC Limited serves a diverse customer Category Male Female Total Male Female Total Male Female Total base comprising healthcare providers, government agencies, and international organizations. Domestically, it supplies pharmaceuticals to hospitals, clinics, and pharmacies across India. Internationally, FDC exports products to over 50+ Permanent Employees 47.95% 18.4% 47.01% 41.97% 18.18% 41.16% 43.17% 18.94% 42.34% countries across Asia, Africa, Europe, and North America. Permanent Workers 8.48% 0% 8.44% 9.57% 0% 9.5% 7% 0% 5% c. A brief on types of customers V. Holding, Subsidiary and Associate Companies (including joint ventures) Operating in the pharmaceutical sector, we serve a diverse range of external stakeholders, including wholesalers, suppliers, 23. (a) Names of holding / subsidiary / associate companies / joint ventures customers, employees, and government institutions. Our key customer groups and partners include: Wholesalers and distributors who handle bulk supply of pharmaceutical products to pharmacies, hospitals, and clinics Suppliers of active Does the entity indicated at pharmaceutical ingredients (APIs), packaging materials, and laboratory equipment essential for drug manufacturing Indicate whether it is Percentage of Sr. Name of the holding/subsidiary/ column A, participate in the Healthcare institutions such as hospitals, clinics, and pharmacies that purchase medicines and healthcare products a holding/ Subsidiary/ shares held by No. associate companies/joint ventures Business Responsibility initiatives for patient use Government bodies and regulatory agencies involved in the approval, monitoring, and procurement of Associate/or Joint Venture listed entity of the listed entity? (Yes/No) pharmaceutical products 1 FDC Inc., USA Wholly Owned Subsidiary 100% No IV. Employees 2 FDC International Limited, UK Wholly Owned Subsidiary 100% No 3 Fair Deal Corporation Wholly Owned Subsidiary 100% No 20. Details as at the end of Financial Year: Pharmaceutical SA (Pty) Limited, a. Employees and Workers (including differently abled) South Africa VI. CSR Details Male Female Sr.No Particulars Total (A) Percentage Percentage 24 a. Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes No. (B) No. (C) (B/A) (C/A) Turnover (in Lacs) (FY 2025-26) Rs 212632.72 Employees Net Worth (in Lacs) (FY 2025-26) Rs 249263.85 1. Permanent Employees (D) 6883 6676 96.99% 207 3.01% 2. Other than Permanent Employees (E) 0 0 0% [Showing first 8,000 characters — download PDF for full document]